International Journal of Molecular Medicine,
Год журнала:
2022,
Номер
49(6)
Опубликована: Апрель 7, 2022
Post‑ischemic
neuroinflammation
induced
by
the
innate
local
immune
response
is
a
major
pathophysiological
feature
of
cerebral
ischemic
stroke,
which
remains
leading
cause
mortality
and
disability
worldwide.
NLR
family
pyrin
domain
containing
(NLRP)3
inflammasome
crucially
mediates
post‑ischemic
inflammatory
responses
via
its
priming,
activation
interleukin‑1β
release
during
hypoxic‑ischemic
brain
damage.
Mitochondrial
dysfunctions
are
among
main
hallmarks
several
diseases,
including
stroke.
In
present
review,
focus
was
addressed
on
role
mitochondria
in
stroke
while
keeping
NLRP3
as
link.
Under
ischemia
hypoxia,
capable
controlling
inflammasome‑mediated
through
mitochondrial
released
contents,
localization
related
proteins.
Thus,
may
be
attractive
targets
to
treat
well
drugs
that
target
process
function
At
present,
certain
have
already
been
studied
clinical
trials.
Frontiers in Immunology,
Год журнала:
2021,
Номер
12
Опубликована: Июнь 23, 2021
Blood-Brain
Barrier
(BBB)
disruption
is
an
important
pathophysiological
process
of
acute
ischemic
stroke
(AIS),
resulting
in
devastating
malignant
brain
edema
and
hemorrhagic
transformation.
The
rapid
activation
immune
cells
plays
a
critical
role
BBB
after
stroke.
Infiltrating
blood-borne
(neutrophils,
monocytes,
T
lymphocytes)
increase
permeability,
as
they
cause
microvascular
disorder
secrete
inflammation-associated
molecules.
In
contrast,
promote
repair
angiogenesis
the
latter
phase
profound
immunological
effects
cerebral
(microglia,
astrocytes,
pericytes)
on
have
been
underestimated
Post-stroke
microglia
astrocytes
can
adopt
both
M1/A1
or
M2/A2
phenotype,
which
influence
integrity
differently.
However,
whether
pericytes
acquire
phenotype
exert
remains
controversial.
Thus,
better
understanding
inflammatory
mechanism
underlying
lead
to
identification
more
promising
biological
targets
develop
treatments
that
minimize
onset
life-threatening
complications
improve
existing
patients.
early
attempts
inhibit
infiltration
circulating
into
by
blocking
adhesion
molecules,
were
successful
experimental
failed
clinical
trials.
Therefore,
new
immunoregulatory
therapeutic
strategies
for
are
desperately
warranted.
Herein,
we
highlight
crosstalk
between
them
following
Using
robust
theoretical
background,
discuss
potential
effective
immunotherapeutic
regulate
permeability
Journal of Neuroinflammation,
Год журнала:
2022,
Номер
19(1)
Опубликована: Июнь 11, 2022
Neuronal
pyroptosis
and
neuroinflammation
with
excess
microglial
activation
are
widely
involved
in
the
early
pathological
process
of
ischemic
stroke.
Repetitive
transcranial
magnetic
stimulation
(rTMS),
as
a
non-invasive
neuromodulatory
technique,
has
recently
been
reported
to
be
anti-inflammatory
regulate
function.
However,
few
studies
have
elucidated
role
mechanism
rTMS
underlying
regulating
neuronal
polarization.We
evaluated
motor
function
middle
cerebral
artery
occlusion/reperfusion
(MCAO/r)
injury
mice
after
1-week
intermittent
theta-burst
(iTBS)
treatment
phase
or
without
depletion
microglia
by
colony-stimulating
factor
1
receptor
(CSF1R)
inhibitor
treatment,
respectively.
We
further
explored
morphological
molecular
biological
alterations
associated
polarization
via
Nissl,
EdU,
TTC,
TUNEL
staining,
electron
microscopy,
multiplex
cytokine
bioassays,
western
blot
assays,
immunofluorescence
staining
RNA
sequencing.ITBS
significantly
protected
against
ischemia/reperfusion
(I/R)
injury-induced
locomotor
deficits
damage,
which
probably
relied
on
regulation
innate
immune
inflammatory
responses,
evidenced
sequencing
analysis.
The
peak
was
confirmed
later
than
that
apoptosis
during
stroke,
mainly
located
more
severe
peri-infarcted
area
compared
apoptosis.
Multiplex
bioassays
showed
iTBS
ameliorated
high
levels
IL-1β,
IL-17A,
TNF-α,
IFN-γ
MCAO/r
group
elevated
level
IL-10.
ITBS
inhibited
expression
pyroptosis-associated
proteins
(i.e.,
Caspase1,
IL-18,
ASC,
GSDMD,
NLRP1)
rather
at
border
infarcted
core.
KEGG
enrichment
analysis
demonstrated
shifted
M1/M2
phenotype
balance
curbing
proinflammatory
M1
(Iba1+/CD86+)
enhancing
M2
(Iba1+/CD206+)
inhibiting
TLR4/NFκB/NLRP3
signaling
pathway.
Depletion
using
CSF1R
(PLX3397)
eliminated
functional
improvements
treatment.rTMS
could
alleviate
I/R
induced
modulating
polarization.
It
is
expected
these
data
will
provide
novel
insights
into
mechanisms
protecting
potential
targets
Theranostics,
Год журнала:
2022,
Номер
12(7), С. 3553 - 3573
Опубликована: Янв. 1, 2022
Rationale:
White
matter
repair
is
critical
for
the
cognitive
and
neurological
functional
recovery
after
ischemic
stroke.M2
microglia
are
well-documented
to
enhance
remyelination
their
extracellular
vesicles
(EVs)
mediate
cellular
function
brain
injury.However,
whether
M2
microglia-derived
EVs
could
promote
white
cerebral
ischemia
its
underlying
mechanism
largely
unknown.Methods:
were
isolated
from
IL-4
treated
(M2-EVs)
untreated
(M0-EVs).Adult
ICR
mice
subjected
90-minute
transient
middle
artery
occlusion
received
intravenous
treatment
seven
consecutive
days.Brain
atrophy
volume,
neurobehavioral
tests
examined
within
28
days
following
ischemia.Immunohistochemistry,
myelin
transmission
electron
microscope
compound
action
potential
measurement
performed
assess
structural
remodeling,
oligodendrogenesis.The
effects
of
M2-EVs
on
oligodendrocyte
precursor
cells
(OPCs)
also
in
vitro.EVs'
miRNA
sequencing,
specific
miR-23a-5p
knockdown
luciferase
reporter
assay
used
explore
mechanism.Results:
reduced
promoted
recovery,
oligodendrogenesis
vivo,
increased
OPC
proliferation,
survival
differentiation
vitro.miR-23a-5p
was
enriched
maturation,
while
knocking
down
reversed
beneficial
both
vitro
vivo.Luciferase
showed
that
directly
targeted
Olig3.Conclusion:
Our
results
demonstrated
communicate
OPCs
through
via
possibly
by
targeting
Olig3
stroke,
suggesting
a
novel
promising
therapeutic
strategy
stroke
demyelinating
disease.
Biomolecules,
Год журнала:
2024,
Номер
14(3), С. 305 - 305
Опубликована: Март 4, 2024
The
majority
of
approved
therapies
for
many
diseases
are
developed
to
target
their
underlying
pathophysiology.
Understanding
disease
pathophysiology
has
thus
proven
vital
the
successful
development
clinically
useful
medications.
Stroke
is
generally
accepted
as
leading
cause
adult
disability
globally
and
ischemic
stroke
accounts
most
common
form
two
main
types.
Despite
its
health
socioeconomic
burden,
there
still
minimal
availability
effective
pharmacological
treatment.
In
this
review,
we
take
an
in-depth
look
at
etiology
stroke,
including
molecular
cellular
changes.
This
followed
by
a
highlight
drugs,
therapies,
complementary
medicines
that
or
undergoing
clinical
trials
treatment
management
stroke.
We
also
identify
unexplored
potential
targets
in
pathogenesis
can
be
exploited
increase
pool
anti-stroke
neuroprotective
agents
through
de
novo
drug
repurposing.
Frontiers in Immunology,
Год журнала:
2024,
Номер
14
Опубликована: Янв. 11, 2024
Ischemic
stroke
(IS),
which
is
the
third
foremost
cause
of
disability
and
death
worldwide,
has
inflammation
cell
as
its
main
pathological
features.
IS
can
lead
to
neuronal
release
factors
such
damage-related
molecular
patterns,
stimulating
immune
system
inflammatory
mediators,
thereby
resulting
in
exacerbating
brain
damage.
Currently,
there
are
a
limited
number
treatment
methods
for
IS,
fact
necessitating
discovery
new
targets.
For
this
review,
current
research
on
ischemic
was
summarized.
The
complex
roles
pathways
principal
cells
(microglia,
astrocyte,
neutrophils,
T
lymphocytes,
monocytes/macrophage)
after
discussed.
mechanisms
interactions
cytokines
involved
these
Moreover,
(pyroptosis,
apoptosis,
necroptosis,
PANoptosis,
ferroptosis)
explored.
Finally,
summary
provided
mechanism
action
natural
pharmacological
active
ingredients
IS.
Despite
significant
recent
progress
remain
many
challenges
that
need
be
overcome.
Frontiers in Cellular Neuroscience,
Год журнала:
2024,
Номер
18
Опубликована: Янв. 25, 2024
Glaucoma
is
a
neurodegenerative
disease
of
the
retina
characterized
by
irreversible
loss
retinal
ganglion
cells
(RGCs)
leading
to
visual
loss.
Degeneration
RGCs
and
their
axons,
as
well
damage
remodeling
lamina
cribrosa
are
main
events
in
pathogenesis
glaucoma.
Different
molecular
pathways
involved
RGC
death,
which
triggered
exacerbated
consequence
number
risk
factors
such
elevated
intraocular
pressure
(IOP),
age,
ocular
biomechanics,
or
low
perfusion
pressure.
Increased
IOP
one
most
important
associated
with
this
pathology
only
for
treatment
currently
available,
nevertheless,
on
many
cases
progression
continues,
despite
control.
Thus,
elevation
not
trigger
glaucomatous
damage,
showing
evidence
that
other
can
induce
death
pathology,
would
be
advance
neurodegeneration.
The
underlying
mechanisms
driving
process
glaucoma
include
ischemia/hypoxia,
mitochondrial
dysfunction,
oxidative
stress
neuroinflammation.
In
glaucoma,
like
disorders,
immune
system
immunoregulation
conducted
mainly
glial
cells,
microglia,
astrocytes,
Müller
cells.
increase
produces
activation
tissue.
Chronic
may
provoke
proinflammatory
state
at
level
inducing
blood
barrier
disruption
death.
modulation
response
constitute
an
interesting
new
approach
Journal of Cerebral Blood Flow & Metabolism,
Год журнала:
2022,
Номер
43(3), С. 325 - 340
Опубликована: Ноя. 2, 2022
Myelination
is
an
important
process
in
the
central
nervous
system
(CNS).
Oligodendrocytes
(OLs)
extend
multiple
layers
to
densely
sheath
on
axons,
composing
myelin
achieve
efficient
electrical
signal
conduction.
The
myelination
during
developmental
stage
maintains
a
balanced
state.
However,
numerous
CNS
diseases
including
neurodegenerative
and
cerebrovascular
cause
demyelination
disrupt
homeostasis,
resulting
inflammation
white
matter
deficits.
Effective
clearance
of
debris
needed
region
demyelination,
which
key
step
for
remyelination
tissue
regeneration.
Microglia
astrocytes
are
major
resident
phagocytic
cells
brain,
may
play
different
or
collaborative
roles
myelination.
participate
through
engulfing
excessive
unneeded
myelin.
They
also
involved
degenerated
accelerating
remyelination,
healthy
inhibiting
remyelination.
This
review
focuses
microglia
phagocytosing
brain
diseased
brain.
In
addition,
interaction
between
mediate
engulfment
summarized.
Theranostics,
Год журнала:
2023,
Номер
13(15), С. 5561 - 5583
Опубликована: Янв. 1, 2023
Rationale:Recent
studies
indicate
that
microglial
activation
and
the
resulting
inflammatory
response
could
be
potential
targets
of
adjuvant
therapy
for
ischemic
stroke.Many
have
emphasized
a
well-established
function
Annexin-A1
(ANXA1)
in
immune
system,
including
regulation
activation.Nevertheless,
few
therapeutic
interventions
targeting
ANXA1
microglia
stroke
been
conducted.In
present
study,
Tat-NTS,
small
peptide
developed
to
prevent
from
entering
nucleus,
was
utilized.We
discovered
underlying
mechanism
Tat-NTS
protect
against
brain
injury.Methods:
Preclinical
were
performed
using
an
oxygen-glucose
deprivation
reperfusion
(OGD/R)
cell
model
vitro
middle
cerebral
artery
occlusion
(MCAO)
animal
vivo.Confocal
imaging
3D
reconstruction
analyses
detecting
protein
expression
subcellular
localization
vivo.Co-immunoprecipitation
(Co-IP),
immunoblotting,
ELISA,
quantitative
real-time
PCR
(qRT-PCR),
Luciferase
reporter
assay
determining
precise
molecular
mechanism.Measurement
on
cytotoxicity
assessed
by
CCK-8
LDH
assay.TUNEL
staining
used
detect
conditioned
medium-mediated
neuronal
apoptosis.Adeno-associated
viruses
(AAVs)
injected
into
cortex,
striatum
hippocampal
CA1
region
adult
male
Cx3cr1-Cre
mice,
further
verify
neurofunctional
outcome
TTC
staining,
modified
Neurological
Severity
Score
(mNSS)
test,
open
field
test
(OFT),
novel
object
recognition
task
(NORT),
Morris
water
maze
(MWM)
long-term
potentiation
(LTP)
Transmission
electron
microscopy
(TEM).
Results:It
observed
administration
led
shift
nucleus
cytoplasm
injury.Notably,
this
accompanied
increase
SUMOylation
transformation
towards
anti-inflammatory
phenotype.We
confirmed
Tat-NTS-induced
mediated
IKKα
degradation
via
NBR1-dependent
selective
autophagy,
then
blocking
NF-κB
pathway.As
result,
release
pro-inflammatory
factors
IL-1β
TNF-α
reduced
both
vivo
experiments.Furthermore,
we
found
peptide's
protective
effect
relieved
neuron
apoptosis.Finally,
Ivyspring
Journal of Neuroinflammation,
Год журнала:
2023,
Номер
20(1)
Опубликована: Фев. 25, 2023
Abstract
Background
Chronic
kidney
disease
(CKD)
is
increasingly
recognized
as
a
stroke
risk
factor,
but
its
exact
relationship
with
cerebrovascular
not
well-understood.
We
investigated
the
development
of
cerebral
small
vessel
using
in
vivo
and
vitro
models
CKD.
Methods
CKD
was
produced
aged
C57BL/6J
mice
an
adenine-induced
tubulointerstitial
nephritis
model.
analyzed
brain
histology
Prussian
blue
staining
to
examine
formation
microhemorrhage
(CMH),
hemorrhagic
component
neuropathological
substrate
MRI-demonstrable
microbleeds.
In
cell
culture
studies,
we
examined
effects
serum
from
healthy
or
patients
gut-derived
uremic
toxins
on
microvascular
endothelial
barrier.
Results
induced
significant
increases
both
creatinine
cystatin
C
levels
(
p
<
0.0001)
without
elevation
systolic
diastolic
blood
pressure.
CMH
significantly
increased
positively
correlated
level
(Spearman
r
=
0.37,
0.01).
Moreover,
Iba-1-positive
immunoreactivity
by
51%
0.001),
phenotypic
switch
resting
activated
microglia,
enhanced
fibrinogen
extravasation
across
blood–brain
barrier
(BBB)
34%
0.05).
On
analysis
stratified
sex,
increase
number
more
pronounced
male
this
greater
compared
female
mice.
Microglial
depletion
PLX3397
diet
decreased
affecting
levels.
Incubation
reduced
transendothelial
electrical
resistance
(TEER)
0.01)
sodium
fluorescein
permeability
0.05)
monolayer.
Uremic
(i.e.,
indoxyl
sulfate,
p-cresyl
trimethylamine-N-oxide)
combination
urea
lipopolysaccharide
marked
drop
TEER
control
group
0.0001).
Conclusions
promotes
independent
pressure
directly
proportional
degree
renal
impairment.
These
are
likely
mediated
part
microglia
associated
BBB
The
latter
related
bacteria-dependent
classically
Overall,
these
findings
demonstrate
important
role
disease.